查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1863097

静脉输液装置市场按产品类型、最终用户、应用、一次性与可重复使用、便携性和材质类型划分－2025-2032年全球预测

Intravenous Equipment Market by Product Type, End User, Application, Disposable Vs Reusable, Portability, Material Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，静脉输液设备市场规模将达到 215.9 亿美元，复合年增长率为 6.29%。

关键市场统计数据
基准年 2024 132.4亿美元
预计年份：2025年 140.7亿美元
预测年份 2032 215.9亿美元
复合年增长率 (%) 6.29%

全面了解临床需求、供应链现况和技术趋势如何重塑各种医疗保健环境中的静脉输液治疗。

静脉输液设备产业处于临床需求与技术可行性的交汇点，受到不断变化的医疗环境、日益严格的感染控制要求以及对以患者为中心的治疗模式日益增长的需求的影响。临床医生依赖各种医疗设备和耗材来安全有效地输注液体、药物和营养物质，而耐用型输液帮浦和一次性配件的协同作用仍然是日常诊疗的核心。随着住院时间的缩短以及门诊和居家医疗的普及，如何平衡便携性、准确性和成本效益已成为医疗服务提供者和製造商的共同策略重点。

除了不断变化的临床环境，供应链韧性和日益严格的监管也已成为采购的首要考量。医疗系统和采购负责人越来越重视生命週期成本、服务连续性和材料合规性，而不仅仅是单位成本。同时，输液帮浦智慧化、互联互通和材料科学领域的创新正在重塑产品蓝图和商业性对话。本导言为报告对临床趋势、采购要务和产品演进的探讨奠定了基础，为所有参与静脉输液治疗的相关人员提供了切实可行的见解。

智慧型设备的普及、护理服务向门诊和家庭环境的转变以及永续性优先事项，正在共同重新定义静脉输液治疗设备的设计、采购和服务模式。

由于三大因素的共同作用，静脉输液设备领域正经历着变革性的变化：技术进步、照护模式的转变以及日益增长的监管和永续性要求。整合安全软体和互通性的智慧型输液帮浦正从选购功能转变为高阶临床环境中的必备功能，这迫使原始设备製造商 (OEM) 和医院 IT 部门投资于设备管理平台和双向资料流。同时，居家输液和门诊护理的兴起推动了对便携式、易用型设备以及专为非临床环境设计的耗材的需求，这使得培训、远端监控和供应物流的重要性日益凸显。

材料创新和环境因素也在推动改变。医疗器材设计人员和采购团队越来越重视传统材料的替代品，以解决塑化剂和废弃物管理方面的问题。同时，製造商正在调整其生产基地和供应商网络，以应对贸易政策的变化和应对危机的计划。这些变化并非孤立发生；临床偏好、采购政策和监管指南形成反馈迴路，加速了某些规格和材料的采用，从而影响原始设备製造商 (OEM) 的研发重点和售后服务模式。

评估近期关税政策对静脉注射医疗设备生态系统的筹资策略、供应商韧性、采购行为和产品生命週期经济学的持久影响

近期政策週期中实施的贸易措施正对静脉输液器材的供应链策略、成本模型和采购决策产生累积影响。关税带来的成本压力迫使製造商和经销商重新评估其全球采购组合，许多企业加快了生产回流，并选择低关税地区的二线供应商，以维持利润率和交货保障。医疗系统和集团采购组织则透过收紧合约条款、提高库存可视性要求以及优先选择能够证明其冗余性和短期交货保证的供应商来应对这些挑战。

这些趋势也会影响产品开发规划。在采购成本不断上涨的环境下，负责人倾向于优先考虑价格波动可预测的耗材以及拥有维护合约、能够平滑生命週期成本的耐用设备。此外，关税会影响材料替代和製造自动化的经济效益，促使企业投资于能够降低劳动密集度并减轻关税负担的高价值工艺。市场参与企业采取的因应策略包括策略性库存、重新谈判供应合约以及加强临床技术与采购部门之间的合作，以检验临床等效替代方案。这些调整会随着时间的推移改变竞争优势。能够透明地管理跨境复杂性并提供持续临床支援的供应商，将在竞标过程中以及建立长期伙伴关係时获得相对优势。

详细的細項分析揭示了产品系列、最终用户环境、临床应用、一次性用品选项、便携性要求和材料选择如何影响采购和设计优先顺序。

细分市场层面的趋势揭示了不同产品系列、最终用户、应用、一次性使用选项、便携性偏好和材料选择等方面的驱动因素和决策标准。在产品类型内部，诸如滴注室、延长管、过滤器和输液器等配件的选择通常受采购週期驱动，采购週期侧重于无菌保证、兼容性和单位经济性；而无翼套管和有翼套管的选择则取决于手术操作环境和临床医生的偏好。导管的选择受临床因素主导，中央静脉导管、週边静脉导管和周边置入中央静脉导管分别适用于不同的治疗路径和感染控制方案。输液帮浦的技术选择最为多样化：弹性体帮浦操作简单且可一次性使用，适用于门诊输液；胰岛素帮浦需要对生命至关重要的精准度和符合人体工学的设计；注射式帮浦满足小剂量、精确给药的需求；而容积式帮浦则是高度危重情况下控制给药的核心。

终端用户环境进一步影响产品的采用和服务模式。门诊医疗机构，例如诊所和诊断中心，优先考虑吞吐量、易用性和一次性使用性，以最大限度地降低人员流动风险。另一方面，居家医疗提供者则优先考虑便携性、病患教育和远端监测功能。医院，无论是综合医院还是专科医院，都会投资于互通性、警报管理和预防性保养计划，以保障病人安全和设备运作。麻醉、加护治疗、营养治疗、肿瘤和疼痛管理等应用领域具有独特的性能和监管要求，这些要求会影响采购决策和供应商选择。一次性设备与可重复使用设备的选择取决于感染控制通讯协定、整体拥有成本分析和环境政策。便携性的考量造成了两种选择：一种是针对行动性最佳化的行动装置，另一种是旨在整合到临床工作流程中的固定係统。聚烯、聚氨酯和聚氯乙烯等材料的选择反映了柔韧性、化学相容性、生物相容性和监管审查之间的权衡。了解这些相互交织的细分因素，可以让製造商和负责人将产品规格与临床工作流程和采购重点保持一致，并设计出满足每个细分市场细微需求的模式。

美洲、欧洲、中东和非洲以及亚太地区的区域市场特征和战略重点将影响製造、监管方法和采用模式。

区域趋势对静脉输液器材的製造、监管路径和应用模式有着深远的影响。在美洲，大型综合医疗保健系统和健全的私人保险体系催生了对兼具临床疗效和成本控制的解决方案的需求。该市场青睐那些能够提供强大服务网路、相容耗材以及与电子健康记录系统成熟互通性的供应商。在欧洲、中东和非洲，不同的监管环境和不断变化的报销机制要求企业制定客製化的打入市场策略。此外，公私混合医疗体系越来越重视以竞标为基础的采购方式，强调全生命週期价值和符合区域安全标准。在亚太地区，医院基础设施的快速投资、对居家医疗日益增长的关注以及充满活力的製造业基础，使该地区既成为重要的需求中心，也是全球生产网络的重要组成部分。

每个地区都面临独特的物流和竞争挑战。在美洲，对服务绩效记录和全面维护协议的重视，给寻求长期合约的供应商设置了很高的门槛。在欧洲、中东和非洲，企业需要具备复杂的监管能力，以及服务各种临床环境的能力，从高度紧急的都市区到资源有限的医疗机构。在亚太地区，技术快速普及和在零件製造中的作用，为策略合作、共同开发和成本竞争性采购创造了机会，同时也需要考虑当地的合规制度和临床合作规范。认识到这些区域差异，企业才能优先考虑投资，并客製化价值提案，以满足不同市场中临床医生、采购团队和监管机构的期望。

竞争格局概述：设备智慧、生命週期服务和供应链敏捷性的创新将决定哪些公司能够获得长期的商业性和临床优势。

静脉输液设备领域的竞争动态取决于产品创新、服务能力和供应可靠性的差异化。主要企业正日益将卓越的硬体效能与支援安全性、数据分析和远端设备管理的软体功能相结合。售后服务和耗材仍然是维繫客户忠诚度的重要来源，而提供透明的生命週期成本模型、快速响应的技术支援和以临床医生为中心的培训的供应商则能确保长期的采购优势。策略伙伴关係、与临床机构的共同开发契约以及对人体工学研究的投资，能够增强产品与市场的契合度，并在专业领域建立稳固的地位。

同时，竞争压力正推动营运效率和敏捷供应链策略的发展。拥有供应商多元化、生产灵活性和监管适应能力的公司能够快速回应政策变化和新兴的临床需求。临床软体与互联设备的整合为新的经营模式创造了机会，例如将收入与设备运作和效能挂钩的订阅服务。鑑于这些趋势，那些能够平衡智慧型设备研发投入、严谨的商业性执行以及完善的售后支援的公司，将更有利于建立长期的客户关係，并拓展到其他临床领域。

製造商和供应商应重点关注以下切实可行的策略重点，以增强医疗设备的互通性、供应链韧性、永续性以及将商业性奖励与临床结果相一致的服务模式。

产业领导者应采取多管齐下的策略，使产品开发、商业模式和营运韧性与不断变化的临床和采购需求保持一致。优先投资于互通性标准和以使用者为中心的设计，以确保输液帮浦及其配件能够无缝整合到电子健康记录 (EHR) 和临床工作流程中，从而减少警报疲劳并提高输液通讯协定的依从性。同时，应实现采购管道多元化并对本地供应商进行认证，以降低贸易政策波动带来的风险，并制定支援库存可见性和快速补货的合约条款。在商业产品中建立强大的培训和远端支援能力，以增强使用者信心，尤其是在临床监管分散的门诊和居家医疗环境中。

经营团队还应将永续性和材料替代性作为策略性差异化因素进行评估，并在临床和监管条件允许的情况下考虑逐步淘汰传统塑胶。同时，应考虑采用新的服务模式，将部分价值提案从独立销售转向按绩效付费合约或设备管理服务，以协调供应商和医疗服务提供者之间的奖励。最后，应加强临床工程、采购和产品开发团队之间的跨职能协作，以加速引入经临床检验的替代方案，并确保采购决策既反映安全要求，也反映长期成本趋势。这些措施将共同增强企业的竞争力，并使企业能够灵活应对监管和市场变化。

方法透明度：整合了临床医生访谈、监管审查、技术规范分析和供应链情境测试的三角验证研究调查方法的描述

本研究采用混合方法，结合定性相关利益者访谈、技术文献综述、监管分析和供应链图谱，整合了各方见解并验证了研究结果。主要资讯来源包括与急诊、门诊和居家医疗机构的临床医生、采购经理、临床工程师和生产主管进行结构化对话，以了解实际决策标准和营运限制。二级资讯来源包括医疗设备监管指南、同行评审的临床研究和製造商技术规范，以检验性能声明和安全性考虑因素。

我们的分析方法包括将访谈主题与已记录的政策和设备规格进行交叉检验，并建立基于情境的评估，以压力测试供应商的适应能力和产品在不同护理路径中的适用性。此调查方法的限制包括监管解读的区域差异以及特定临床领域技术采纳速度的差异。为了降低这些因素的影响，我们与独立的临床顾问和采购专家进行了迭代检验，以确保研究结果对寻求实用见解的决策者俱有相关性和实用性。

从整体观点来看，需要将医疗设备专业知识、供应可靠性和永续实践融入长期静脉输液装置策略中。

总之，静脉输液设备策略如今已成为一项多维度的挑战，它不仅关乎设备性能，还包括互联互通、供应链韧性和环境保护。临床医生和采购负责人面临着相互衝突的优先事项：一方面要确保病人安全和输液准确性，另一方面要控制总成本并维持业务连续性。能够平衡产品创新、务实的服务交付和透明的供应策略，以满足不断变化的医疗模式的需求，同时又不损害安全性和可及性的企业，将是市场上最成功的参与企业。

决策者应将目前的市场动态视为重塑价值链各环节关係的契机，优先选择那些既展现出临床同理心又具备营运可靠性的合作伙伴。透过将采购标准与长期设备管理政策相衔接，并采用以服务为导向的商业模式，相关人员可以减少设备推广应用过程中的阻力，并为持续改善输液安全性和病患体验铺平道路。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 为防止化疗药物污染，越来越多采用封闭式输送系统。
  • 智慧型输液帮浦正与医院资讯系统整合，以提高用药安全性。
  • 无针连接器的研发降低了导管相关血流感染的发生率。
  • 主要製造商越来越重视静脉注射静脉输液包装材料的永续性
  • 无线远端监测静脉输液技术的进步有助于改善患者预后
  • 为最大限度减少加护治疗环境中的输液错误，对整合药物库软体的需求激增
  • 在院外环境中，穿戴式输液帮浦在持续皮下治疗的应用日益广泛
  • 扩大一次性生物处理袋的使用范围，以简化静脉注射药物生产的生产流程。
  • 肝素涂层导管的创新可通畅性
  • 引入方便病患使用的配药装置，以提高医院药局无菌静脉输液配製效率

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的静脉输液设备市场

  • 配件
    • 滴液室
    • 延长管
    • 筛选
    • 点滴器
  • 套管
    • 无翅
    • 长着翅膀
  • 导管
    • 中央
    • 外围
    • 周边置入中央静脉导管
  • 点滴帮浦
    • 弹性体泵
    • 胰岛素帮浦
    • 注射式帮浦
    • 容积式泵

9. 依最终用户分類的静脉输液设备市场

  • 门诊治疗
    • 诊所
    • 诊断中心
  • 居家医疗
  • 医院
    • 一般的
    • 专科诊所

第十章 依应用分類的静脉输液装置市场

  • 麻醉
  • 加护治疗
  • 营养疗法
  • 肿瘤学
  • 疼痛管理

第十一章 静脉输液装置市场（依一次性装置和可重复使用装置划分）

  • 一次性的
  • 可重复使用的

第十二章 依便携性分類的静脉输液设备市场

  • 携带式的
  • 固定式

第十三章 依材料类型分類的静脉输液装置市场

  • 聚烯
  • 聚氨酯
  • 聚氯乙烯

14. 按地区分類的静脉输液设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 静脉输液装置市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各国静脉输液设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Becton, Dickinson and Company
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Fresenius Kabi AG
    • Terumo Corporation
    • ICU Medical, Inc.
    • Smiths Medical, Inc.
    • Nipro Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Medtronic plc
Product Code: MRR-F6513A06BEE9

The Intravenous Equipment Market is projected to grow by USD 21.59 billion at a CAGR of 6.29% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 13.24 billion
Estimated Year [2025] USD 14.07 billion
Forecast Year [2032] USD 21.59 billion
CAGR (%) 6.29%

A comprehensive orientation to the clinical imperatives, supply chain realities, and technological trajectories that are reshaping intravenous therapy delivery across care settings

The intravenous equipment arena stands at the intersection of clinical necessity and technological possibility, shaped by changing care settings, heightened infection control expectations, and accelerating demand for patient-centric delivery models. Clinicians rely on a broad array of devices and consumables to deliver fluids, medications, and nutrition safely and effectively, and the interplay between durable infusion pumps and single-use accessories remains central to daily practice. As inpatient stays shorten and outpatient and home-based care expand, the balance between portability, precision, and cost-efficiency has become a strategic priority for providers and manufacturers alike.

Beyond clinical dynamics, supply chain resilience and regulatory rigor have moved to the forefront of buyer criteria. Health systems and procurement leaders increasingly evaluate not only unit price but also lifecycle costs, service continuity, and material compliance. Simultaneously, innovation in pump intelligence, connectivity, and materials science is redefining product roadmaps and commercial conversations. This introduction frames the report's exploration of clinical trends, procurement imperatives, and product evolution, providing a foundation for actionable insights across stakeholders involved in intravenous therapy delivery.

How smart device integration, care delivery migration to outpatient and home settings, and sustainability priorities are jointly redefining intravenous equipment design, procurement, and service models

The landscape for intravenous equipment is undergoing transformative shifts driven by three converging forces: technological advancement, care model migration, and heightened regulatory and sustainability expectations. Smart infusion pumps with integrated safety software and interoperability capabilities are moving from optional enhancements to core requirements in higher acuity settings, prompting OEMs and hospital IT teams to invest in device management platforms and bidirectional data flows. At the same time, the proliferation of home infusion and ambulatory care has elevated demand for portable, user-friendly devices and single-use accessories designed for nonclinical environments, which places new emphasis on training, remote monitoring, and supply logistics.

Material innovation and environmental considerations are also driving change. Device designers and procurement teams are increasingly prioritizing alternatives to legacy materials to address concerns about plasticizers and waste management. Meanwhile, manufacturers are reconfiguring production footprints and supplier networks in response to trade policy shifts and resilience planning. Collectively, these shifts are not isolated; they create feedback loops in which clinical preferences, procurement policies, and regulatory guidance accelerate adoption of particular form factors and materials, thereby influencing OEM development priorities and aftermarket service models.

Assessing the persistent effects of recent tariff policies on sourcing strategies, supplier resilience, procurement behavior, and product lifecycle economics within the intravenous equipment ecosystem

Trade measures implemented in recent policy cycles have exerted a cumulative influence on supply chain strategies, costing models, and sourcing decisions for intravenous equipment. Tariff-driven cost pressures have compelled manufacturers and distributors to re-evaluate global sourcing mixes, with many accelerating reshoring efforts or qualifying secondary suppliers in lower-tariff jurisdictions to preserve margin and delivery reliability. Health systems and group purchasing organizations have responded by tightening contract terms, extending inventory visibility requirements, and placing a premium on suppliers that can demonstrate redundancy and near-term delivery assurances.

These dynamics also shape product roadmaps. When procurement faces elevated input costs, buyers tend to prioritize consumables with predictable pricing and durable equipment with service agreements that smooth lifecycle expenses. In addition, tariffs can influence the economics of material substitution and manufacturing automation, incentivizing investment in higher-value processes that reduce labor intensity or lower tariff exposure. Mitigation strategies adopted by market participants include strategic stockpiling, renegotiation of supply contracts, and enhanced collaboration between clinical engineering and procurement to validate clinically equivalent alternatives. Over time, such adjustments alter competitive positioning: suppliers that can transparently manage cross-border complexity and provide consistent clinical support gain relative advantage in tender processes and long-term partnerships.

In-depth segmentation analysis revealing how product families, end-user settings, clinical applications, disposability choices, portability demands, and material selections determine procurement and design priorities

Segment-level dynamics reveal distinct drivers and decision criteria across product families, end users, applications, disposability choices, portability preferences, and material selection. Within product types, accessories such as drip chambers, extension tubing, filters, and infusion sets are often governed by procurement cycles that prize sterility assurance, compatibility, and unit economics, whereas cannula choices between non-winged and winged variants hinge on procedural context and clinician preference. Catheter selection is clinically driven, with central, peripheral, and peripherally inserted central catheters each serving different care pathways and infection control regimes. Infusion pumps present the broadest range of technical trade-offs: elastomeric pumps offer simplicity and disposability for ambulatory infusion, insulin pumps demand life-critical accuracy and user ergonomics, syringe pumps address small-volume precision needs, and volumetric pumps are central to controlled delivery in higher acuity settings.

End-user context further shapes product adoption and service models. Ambulatory care settings such as clinics and diagnostic centers focus on throughput, ease of use, and disposability to minimize turnover risk, while home healthcare providers prioritize portability, patient education, and remote monitoring capabilities. Hospitals, whether general or specialty, invest in interoperability, alarm management, and preventive maintenance programs to protect patient safety and asset uptime. Application areas like anesthesia, critical care, nutrition therapy, oncology, and pain management impose distinct performance and regulatory expectations that influence purchasing decisions and vendor selection. The disposable versus reusable calculus is informed by infection control protocols, total cost of ownership analyses, and environmental policy. Portability considerations create a bifurcation between portable devices optimized for mobility and stationary systems designed for integration into clinical workflows. Material selection among polyolefin, polyurethane, and polyvinyl chloride reflects trade-offs between flexibility, chemical compatibility, biocompatibility, and regulatory scrutiny. Understanding these intersecting segmentation vectors enables manufacturers and purchasers to align product specifications with clinical workflows and procurement priorities, and to design service models that respond to the nuanced needs of each segment.

Regional market signatures and strategic priorities across the Americas, Europe Middle East and Africa, and Asia-Pacific that influence manufacturing, regulatory approach, and adoption patterns

Regional dynamics have profound implications for manufacturing, regulatory pathways, and adoption patterns across the intravenous equipment landscape. In the Americas, large integrated health systems and a robust private payer environment create demand for solutions that combine clinical performance with cost containment; this market favors suppliers that offer strong service networks, compatible consumables, and demonstrated interoperability with electronic health records. Across Europe, the Middle East, and Africa, regulatory diversity and variable reimbursement landscapes require tailored market entry strategies, and hybrid public-private systems often prioritize tender-based procurement that emphasizes total lifecycle value and compliance with regional safety standards. In the Asia-Pacific region, rapid investment in hospital infrastructure, a growing emphasis on home healthcare, and a dynamic manufacturing base position the region as both a major demand center and a critical node in global production networks.

Each region also presents distinct logistical and competitive challenges. The Americas' emphasis on documented service performance and bundled maintenance agreements raises the bar for suppliers seeking long-term contracts. Europe, the Middle East, and Africa demand nuanced regulatory navigation and an ability to serve heterogeneous clinical contexts, from high-acuity urban centers to resource-constrained facilities. Asia-Pacific's pace of technological adoption and its role in component manufacturing create opportunities for strategic partnerships, joint development, and cost-competitive sourcing, while also requiring attention to local compliance regimes and language of clinical engagement. Recognizing these regional signatures enables companies to prioritize investments and tailor value propositions to meet the expectations of clinicians, procurement teams, and regulators across diverse markets.

Competitive landscape overview where innovation in device intelligence, lifecycle services, and supply chain agility determines who captures long-term commercial and clinical advantage

Competitive dynamics within the intravenous equipment space are defined by differentiation along product innovation, service capability, and supply reliability. Leading companies increasingly combine hardware excellence with software-enabled features that support safety, analytics, and remote device management. Aftermarket services and consumables remain a durable source of customer lock-in, and providers that offer transparent lifecycle cost models, rapid technical support, and clinician-focused training secure long-term procurement advantages. Strategic partnerships, co-development arrangements with clinical institutions, and investments in human factors research bolster product-market fit and create defensible positions in specialty segments.

At the same time, competitive pressure incentivizes operational efficiency and nimble supply chain strategies. Companies that excel in supplier diversification, manufacturing flexibility, and regulatory agility can respond more rapidly to policy changes and emergent clinical needs. The convergence of clinical software and connected devices opens opportunities for new commercial models, including subscription-based service offerings that align revenue with device uptime and performance. Given these dynamics, firms that balance R&D investment in smart device capabilities with disciplined commercial execution and robust post-sale support will be best positioned to capture durable customer relationships and to expand into adjacent care settings.

Practical strategic priorities for manufacturers and providers to enhance device interoperability, supply resilience, sustainability, and service models that align commercial incentives with clinical outcomes

Industry leaders should adopt a multi-pronged strategy that aligns product development, commercial models, and operational resilience with evolving clinical and procurement expectations. Prioritize investments in interoperability standards and user-centered design to ensure that pumps and accessories integrate seamlessly into electronic health records and clinical workflows, thereby reducing alarm fatigue and improving adherence to infusion protocols. Simultaneously, diversify sourcing and qualify regional suppliers to reduce exposure to trade policy volatility, while developing contractual terms that support inventory visibility and rapid replenishment. Embedding robust training and remote support capabilities into commercial offerings will enhance user confidence, particularly in ambulatory and home-care contexts where clinical oversight is distributed.

Leaders should also evaluate sustainability and material substitution as strategic differentiators, exploring transitions away from legacy plastics where clinically and regulatorily feasible. Consider novel service models that shift part of the value proposition from unit sales to outcome-based contracts or managed device services, aligning incentives across providers and suppliers. Finally, cultivate cross-functional engagement between clinical engineering, procurement, and product teams to accelerate adoption of clinically validated alternatives and to ensure procurement decisions reflect both safety imperatives and long-term cost dynamics. These measures collectively strengthen competitive position and enable organizations to respond nimbly to regulatory and market shifts.

Methodological transparency describing a triangulated research approach that integrates clinician interviews, regulatory review, technical specification analysis, and supply chain scenario testing

This research synthesizes insights from a mixed-methods approach combining qualitative stakeholder interviews, technical literature review, regulatory analysis, and supply chain mapping to triangulate findings. Primary inputs included structured conversations with clinicians across acute, ambulatory, and home settings, procurement leaders, clinical engineers, and manufacturing executives to capture real-world decision criteria and operational constraints. Secondary sources encompassed device guidance from regulatory authorities, peer-reviewed clinical studies, and manufacturer technical specifications to validate performance claims and safety considerations.

Analytical methods involved cross-validating interview themes with documented policies and device specifications, and constructing scenario-based assessments to stress-test supplier resilience and product fit across diverse care pathways. Limitations of the methodology include potential variability in regional regulatory interpretation and the pace of technological adoption in specific clinical niches. To mitigate these factors, findings were subjected to iterative validation with independent clinical advisors and procurement specialists to ensure relevance and practical applicability for decision-makers seeking actionable intelligence.

Summative perspective emphasizing the need to integrate device intelligence, supply reliability, and sustainable practices into long-term intravenous equipment strategies

In conclusion, intravenous equipment strategy is now a multidimensional challenge that extends beyond device performance to encompass connectivity, supply chain resilience, and environmental stewardship. Clinicians and procurement leaders face competing priorities: ensuring patient safety and precision of delivery while managing total cost and operational continuity. The most successful market participants will be those that harmonize product innovation with practical service offerings and transparent supply strategies, enabling providers to meet the demands of shifting care models without compromising safety or accessibility.

Decision-makers should view current market dynamics as an opportunity to rearchitect relationships across the value chain, privileging partners who demonstrate both clinical empathy and operational reliability. By aligning procurement criteria with long-term device stewardship and by adopting service-oriented commercial models, stakeholders can reduce friction in device adoption and create pathways for sustained improvement in infusion safety and patient experience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of closed system transfer devices to prevent chemotherapy drug contamination
  • 5.2. Integration of smart infusion pumps with hospital information systems to enhance medication safety
  • 5.3. Development of needle-free connectors to reduce catheter-related bloodstream infections
  • 5.4. Increased focus on sustainability in IV disposable packaging materials by major manufacturers
  • 5.5. Advancement in wireless remote monitoring of intravenous fluid delivery to improve patient outcomes
  • 5.6. Surge in demand for integrated drug library software to minimize infusion errors in critical care settings
  • 5.7. Growing implementation of on-body infusion pumps for continuous subcutaneous therapies outside hospital settings
  • 5.8. Expansion of single-use bioprocessing bags for intravenous drug manufacturing to streamline production workflows
  • 5.9. Innovations in heparin-coated catheters for prolonged patency in long-term infusion therapies
  • 5.10. Adoption of near-patient compounding units to improve sterile IV preparation efficiency in hospital pharmacies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravenous Equipment Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Drip Chambers
    • 8.1.2. Extension Tubing
    • 8.1.3. Filters
    • 8.1.4. Infusion Sets
  • 8.2. Cannula
    • 8.2.1. Non Winged
    • 8.2.2. Winged
  • 8.3. Catheters
    • 8.3.1. Central
    • 8.3.2. Peripheral
    • 8.3.3. Peripherally Inserted Central
  • 8.4. Infusion Pumps
    • 8.4.1. Elastomeric Pumps
    • 8.4.2. Insulin Pumps
    • 8.4.3. Syringe Pumps
    • 8.4.4. Volumetric Pumps

9. Intravenous Equipment Market, by End User

  • 9.1. Ambulatory Care
    • 9.1.1. Clinics
    • 9.1.2. Diagnostic Centers
  • 9.2. Home Healthcare
  • 9.3. Hospital
    • 9.3.1. General
    • 9.3.2. Specialty Clinics

10. Intravenous Equipment Market, by Application

  • 10.1. Anesthesia
  • 10.2. Critical Care
  • 10.3. Nutrition Therapy
  • 10.4. Oncology
  • 10.5. Pain Management

11. Intravenous Equipment Market, by Disposable Vs Reusable

  • 11.1. Disposable
  • 11.2. Reusable

12. Intravenous Equipment Market, by Portability

  • 12.1. Portable
  • 12.2. Stationary

13. Intravenous Equipment Market, by Material Type

  • 13.1. Polyolefin
  • 13.2. Polyurethane
  • 13.3. Polyvinyl Chloride

14. Intravenous Equipment Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Intravenous Equipment Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Intravenous Equipment Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Becton, Dickinson and Company
    • 17.3.2. Baxter International Inc.
    • 17.3.3. B. Braun Melsungen AG
    • 17.3.4. Fresenius Kabi AG
    • 17.3.5. Terumo Corporation
    • 17.3.6. ICU Medical, Inc.
    • 17.3.7. Smiths Medical, Inc.
    • 17.3.8. Nipro Corporation
    • 17.3.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 17.3.10. Medtronic plc

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. INTRAVENOUS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. INTRAVENOUS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAVENOUS EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 304. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 320. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 322. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY